All In MedTech

FDA Clearance Tracker · P960030-S031

PASSIVE PLUS, ISOFLEX S&P, AND ISOFLEX OPTIM LEADS

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 13, 2015 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Aug 13, 2015

Approved

Time to decision

1,911 days

Received May 20, 2010. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P960030-S031
Device name
PASSIVE PLUS, ISOFLEX S&P, AND ISOFLEX OPTIM LEADS
Applicant location
Sylmar, CA
Received
May 20, 2010
Decided
Aug 13, 2015
Decision
Approved
Supplement type
Normal 180 Day Track
Original approval
P960030

Device type

Device class
Class III

Every decision under product code NVY

FDA's approval statement

As written in FDA's record.

APPROVAL FOR MCRD AND STEROID COATING TEST METHODOLOGIES, SPECIFICATIONS, STABILITY PROTOCOLS AND OTHER MANUFACTURING PROCESSES TO MEET THE REQUIREMENTS IN THE AGREED UPON STEROID COMMITMENT LETTER.

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.